CIR Vaccine Trials – Currently Enrolling

Project SAVE (Support a Vaccine Effort) is the adult recruitment program at the Center for Immunization Research.  The program is used to screen adult potential study participants to help determine their eligibility for specific clinical vaccine studies at the CIR.  Check below for studies that are currently enrolling.

Inpatient

Zika Vaccine Inpatient Study (CIR 316)

The purpose of this study is to learn about the clinical presentation and duration of shedding of the Zika virus in healthy adults.  The study is:

  • 6 months long
  • enrolling FEMALES ONLY 18-40 years old
  • includes 2-3 screening visits, one 9 day inpatient stay and 14 outpatient follow up visits
  • pays up to $5000 for completion of all study procedures

Complete the Pre-Screening Survey to see if you qualify for an in-person screening visit

Complete the CIR Contact Form to be contacted by a CIR staff member

More about  Zika Virus

Learn More

Outpatient

BCG Study

BCG vaccine is traditionally used to prevent TB infections and is a routine vaccine for children in epidemic countries. It is not a routine vaccination in the US, considering the low prevalence of TB.

The purpose of this study is to determine how the BCG vaccine affects the immune system and whether it can provide some degree of protection against a variety of infections. The study is:

  • 6 months long
  • enrolling people 18-65 years old
  • includes 1-2 screening visits, 1 vaccination visit, 2 follow up phone calls and 3 follow up visits
  • pays up to $440 for completion of all study procedures

Complete the Pre-Screening Survey to see if you qualify for an in-person screening visit

Complete the CIR Contact Form to be contacted by a CIR staff member

Learn More
Translate »